Dynavax Technologies
DVAX
#5495
Rank
HK$9.95 B
Marketcap
HK$84.77
Share price
-0.64%
Change (1 day)
-15.09%
Change (1 year)

Dynavax Technologies (DVAX) - Cash on Hand

Cash on Hand as of September 2025 : HK$5.04 Billion

According to Dynavax Technologies 's latest financial reports the company has HK$5.04 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dynavax Technologies - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$5.54 B-4.41%
2023-12-31HK$5.79 B18.83%
2022-12-31HK$4.87 B14.6%
2021-12-31HK$4.25 B232.74%
2020-12-31HK$1.27 B8.75%
2019-12-31HK$1.17 B3.22%
2018-12-31HK$1.13 B-23.97%
2017-12-31HK$1.49 B137.42%
2016-12-31HK$0.63 B-58.47%
2015-12-31HK$1.52 B59.78%
2014-12-31HK$0.95 B-35.22%
2013-12-31HK$1.46 B51.4%
2012-12-31HK$0.96 B9.58%
2011-12-31HK$0.88 B57.63%
2010-12-31HK$0.56 B97.22%
2009-12-31HK$0.28 B-46.19%
2008-12-31HK$0.52 B-23.1%
2007-12-31HK$0.68 B21.47%
2006-12-31HK$0.56 B-2.73%
2005-12-31HK$0.58 B13.81%
2004-12-31HK$0.51 B126.88%
2003-12-31HK$0.22 B-1.66%
2002-12-31HK$0.22 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Agenus
AGEN
HK$26.91 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$30.83 B 511.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$141.78 B 2,711.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$57.20 B 1,034.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$63.69 B 1,163.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
HK$34.59 B 586.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$116.64 B 2,213.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$17.14 B 240.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
HK$73.52 B 1,357.98%๐Ÿ‡บ๐Ÿ‡ธ USA